The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics

Laura C. Coates, William Tillett, David Chandler, Philip Helliwell, Eleanor Korendowych, Stuart Kyle, Iain B. McInnes, Susan Oliver, Anthony D. Ormerod, Catherine Smith,

Lara D. Veeken · 2013 · 88 citations · 79 references

DOIFull text

Open access

Abstract

PsA is a chronic inflammatory arthropathy affecting up to 40% of patients with skin or nail psoriasis. It is considered a type of seronegative spondyloarthritis and can cause arthritis, enthesitis, dactylitis and axial inflammation. The use of anti-TNF therapy for the treatment of inflammatory arthritis, including PsA, has revolutionized therapeutic options in rheumatology.

References

79